Preventing sudden cardiac death in athletes
Sudden cardiac death in athletes aged less than 35 years is the leading cause of medical death in this subgroup, with an estimated incidence of 1 in 50 000 to 1 in 80 000 athletes per year. it is most commonly caused by an underlying genetic heart disorder, such as hypertrophic cardiomyopathy.
In this podcast Christopher Semsarian, professor of... (Source: The BMJ Podcast)
Source: The BMJ Podcast - March 20, 2015 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Preventing sudden cardiac death in athletes
Sudden cardiac death in athletes aged less than 35 years is the leading cause of medical death in this subgroup, with an estimated incidence of 1 in 50 000 to 1 in 80 000 athletes per year. it is most commonly caused by an underlying genetic heart disorder, such as hypertrophic cardiomyopathy.
In this podcast Christopher Semsarian, professor of... (Source: The BMJ Podcast)
Source: The BMJ Podcast - March 20, 2015 Category: Journals (General) Authors: BMJ talk medicine Source Type: podcasts
Preventing sudden cardiac death in athletes
Sudden cardiac death in athletes aged less than 35 years is the leading cause of medical death in this subgroup, with an estimated incidence of 1 in 50 000 to 1 in 80 000 athletes per year. it is most commonly caused by an underlying genetic heart disorder, such as hypertrophic cardiomyopathy.
In this podcast Christopher Semsarian, professor of medicine at the University of Sydney, joins us to discuss the diagnosis of cardiac changes and prevention of death in this population.
Read the full clinical review:
http://www.bmj.com/content/350/bmj.h1218 (Source: The BMJ Podcast)
Source: The BMJ Podcast - March 20, 2015 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Genetics and Cardiomyopathy
(Source: Mayo Clinic - Medical Edge Radio)
Source: Mayo Clinic - Medical Edge Radio - November 26, 2013 Category: Consumer Health Advice Authors: Mayo Clinic Source Type: podcasts
Zoster after anti-TNF treatment of RA, fibrosis and mortality in dilated cardiomyopathy, myocardial wall thinning as a sign of CAD, and more.
Editor's Audio Summary by J. Michael Gaziano, MD, MPH, Contributing Editor, the Journal of the American Medical Association, for the March 06, 2013 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - March 5, 2013 Category: Journals (General) Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts
#7: New guidelines for hypertrophic cardiomyopathy with Dr Bernard Gersh
New guidelines for hypertrophic cardiomyopathy with Dr Bernard Gersh (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - May 30, 2012 Category: Cardiology Authors: theheart.org Tags: Mayo Clinic Talks Source Type: podcasts
